Fresenius Medical Care (NYSE:FMS) Shares Gap Up – Time to Buy?

Fresenius Medical Care AG (NYSE:FMS) shares gapped up prior to trading on Thursday . The stock had previously closed at $24.73, but opened at $25.85. Fresenius Medical Care shares last traded at $25.74, with a volume of 96,490 shares changing hands.

Analyst Upgrades and Downgrades

A number of equities analysts have recently weighed in on the company. Truist Financial increased their price target on Fresenius Medical Care from $23.00 to $25.00 and gave the stock a “hold” rating in a report on Monday, January 6th. StockNews.com raised Fresenius Medical Care from a “hold” rating to a “strong-buy” rating in a research note on Wednesday, February 5th.

Fresenius Medical Care Trading Down 6.7 %

The stock has a market cap of $14.05 billion, a price-to-earnings ratio of 19.79, a P/E/G ratio of 0.76 and a beta of 0.93. The company has a debt-to-equity ratio of 0.42, a current ratio of 1.37 and a quick ratio of 1.02. The business’s 50 day moving average is $24.14 and its 200 day moving average is $22.65.

Institutional Inflows and Outflows

Institutional investors have recently added to or reduced their stakes in the company. Versant Capital Management Inc grew its position in Fresenius Medical Care by 1,410.9% during the 1st quarter. Versant Capital Management Inc now owns 6,648 shares of the company’s stock worth $166,000 after purchasing an additional 6,208 shares during the last quarter. Forum Financial Management LP acquired a new position in Fresenius Medical Care in the 4th quarter valued at about $247,000. Vident Advisory LLC raised its stake in Fresenius Medical Care by 11.8% during the 4th quarter. Vident Advisory LLC now owns 23,410 shares of the company’s stock valued at $530,000 after acquiring an additional 2,464 shares during the last quarter. Squarepoint Ops LLC acquired a new stake in Fresenius Medical Care during the 4th quarter worth approximately $290,000. Finally, Point72 Asset Management L.P. purchased a new position in shares of Fresenius Medical Care in the 4th quarter valued at approximately $850,000. Institutional investors and hedge funds own 8.37% of the company’s stock.

About Fresenius Medical Care

Fresenius Medical Care AG provides dialysis and related services for individuals with renal diseases in Germany, North America, and internationally. The company offers dialysis treatment and related laboratory and diagnostic services through a network of outpatient dialysis clinics; materials, training, and patient support services comprising clinical monitoring, follow-up assistance, and arranging for delivery of the supplies to the patient's residence; and dialysis services under contract to hospitals in the United States for the hospitalized end-stage renal disease (ESRD) patients and for patients suffering from acute kidney failure.